Last reviewed · How we verify

NCT05343442

Percutaneous Tracheostomy

Completed Phase 4 Last updated 25 April 2022
What this trial tests

Phase 4 trial testing Percutaneous tracheostomy in Tracheostomy in 386 participants. Completed in 15 March 2022.

Timeline
19 December 2021
Primary endpoint
15 March 2022
15 March 2022

Quick facts

Lead sponsorAlexandria University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment386
Start date19 December 2021
Primary completion15 March 2022
Estimated completion15 March 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

18 and older, any sex, with Tracheostomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Description of a technical modification of percutaneous tracheostomy that involves a safety method for confirming the intratracheal location of the needle at the time of puncture, with preventing serious complications such as false passage or damage to the posterior tracheal wall, without coadjuvant technique

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Percutaneous tracheostomy

Trials testing the same drug.

Other recruiting trials for Tracheostomy

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05343442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing